Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nutrient balance modulation refers to the overall process by which cellular and organismal systems sense, integrate, and respond to changes in nutrient availability, typically via intertwined signaling cascades involving key nutrient-sensing pathways such as the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), and insulin/insulin-like growth factor signaling. These pathways control vital physiological processes including metabolism, energy homeostasis, growth, proliferation, autophagy, and longevity. While not a single molecular target, the concept encompasses multiple regulatory proteins and pathways that are individually considered therapeutic targets in contexts such as metabolic disease, cancer, and aging.
null (mechanisms relate to specific pathways, e.g., mTOR inhibition, AMPK activation, SIRT1 modulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nutrient balance modulation.